Search papers, labs, and topics across Lattice.
This paper introduces Sample Efficient Generative Optimization (SEGO), a novel framework that enhances Bayesian optimization for molecular design by adaptively generating candidates based on a probabilistic surrogate model. By integrating a generative model that proposes new molecules in promising regions of chemical space, SEGO significantly reduces the number of required evaluations, achieving state-of-the-art performance on the practical molecular optimization benchmark. Notably, SEGO uses only one-tenth of the oracle calls needed by existing methods, facilitating more efficient drug discovery and materials design processes.
SEGO slashes the number of evaluations needed for molecular optimization by 90%, revolutionizing the search for viable drug candidates.
Molecular optimization in drug discovery, materials design, and catalysis requires searching vast chemical spaces under tight evaluation budgets, since high-fidelity oracles and experimental measurements are costly. The practical impact of an optimization method therefore hinges on its sample efficiency: how few evaluations it needs to find strong candidates. We introduce Sample Efficient Generative Optimization (SEGO), a framework for Bayesian optimization on adaptively generated molecules. In SEGO, a probabilistic surrogate model forms a hypothesis about where hits lie in chemical space, a generative model is steered to propose candidates in that region, the most promising candidate is selected via an acquisition function, and the resulting oracle call is used both to sharpen the surrogate and to anchor the generator in real reward. SEGO attains state-of-the-art performance on the practical molecular optimization (PMO) benchmark using only one tenth of the oracle calls consumed by other methods, and on a multiparameter docking task it reaches ten hits in roughly half the oracle calls of existing approaches. These gains move molecular optimization closer to campaigns driven by direct experimental feedback.
